These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17870166

  • 1. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K, Sacks SH, Sheerin NS.
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [Abstract] [Full Text] [Related]

  • 2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 3. Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells.
    Li K, Zhou W, Hong Y, Sacks SH, Sheerin NS.
    BMC Microbiol; 2009 Mar 31; 9():64. PubMed ID: 19335887
    [Abstract] [Full Text] [Related]

  • 4. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
    Fine DP, Harper BL, Carpenter ED, Davis CP, Cavallo T, Guckian JC.
    J Clin Invest; 1980 Sep 31; 66(3):465-72. PubMed ID: 6105165
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P, Bjornson AB.
    J Immunol; 1982 Jun 31; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract] [Full Text] [Related]

  • 6. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
    Rainard P.
    Immunology; 1993 Aug 31; 79(4):648-52. PubMed ID: 8406591
    [Abstract] [Full Text] [Related]

  • 7. [The role of the complement system in the defence against infections and new ways of assessing the activation routes].
    Seelen MA, Trouw LA, Daha A, Roos A.
    Ned Tijdschr Geneeskd; 2004 Nov 20; 148(47):2318-23. PubMed ID: 15587049
    [Abstract] [Full Text] [Related]

  • 8. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ.
    J Infect Dis; 2009 Jul 15; 200(2):263-72. PubMed ID: 19522648
    [Abstract] [Full Text] [Related]

  • 9. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE.
    Mol Immunol; 2007 Mar 15; 44(8):1819-26. PubMed ID: 17101176
    [Abstract] [Full Text] [Related]

  • 10. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.
    J Immunol Methods; 2005 Mar 15; 298(1-2):35-45. PubMed ID: 15847795
    [Abstract] [Full Text] [Related]

  • 11. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
    Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, Walport MJ, Botto M.
    Proc Natl Acad Sci U S A; 2002 Dec 24; 99(26):16969-74. PubMed ID: 12477926
    [Abstract] [Full Text] [Related]

  • 12. Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors.
    Appledorn DM, McBride A, Seregin S, Scott JM, Schuldt N, Kiang A, Godbehere S, Amalfitano A.
    Gene Ther; 2008 Dec 24; 15(24):1606-17. PubMed ID: 18615115
    [Abstract] [Full Text] [Related]

  • 13. Current concepts of molecular defence mechanisms operative during urinary tract infection.
    Weichhart T, Haidinger M, Hörl WH, Säemann MD.
    Eur J Clin Invest; 2008 Oct 24; 38 Suppl 2():29-38. PubMed ID: 18826479
    [Abstract] [Full Text] [Related]

  • 14. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ, Laumonier T, Aebi C, Mohacsi PJ, Rieben R.
    Xenotransplantation; 2004 Mar 24; 11(2):141-8. PubMed ID: 14962276
    [Abstract] [Full Text] [Related]

  • 15. Uropathogenic Escherichia coli as a model of host-parasite interaction.
    Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D, Lundstedt AC, Ragnarsdottir B, Svensson M, Wullt B.
    Curr Opin Microbiol; 2006 Feb 24; 9(1):33-9. PubMed ID: 16406777
    [Abstract] [Full Text] [Related]

  • 16. Impact of Toll-like receptor signalling on urinary tract infection.
    Scherberich JE, Hartinger A.
    Int J Antimicrob Agents; 2008 Feb 24; 31 Suppl 1():S9-14. PubMed ID: 17942281
    [Abstract] [Full Text] [Related]

  • 17. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli.
    Li K, Feito MJ, Sacks SH, Sheerin NS.
    J Immunol; 2006 Aug 15; 177(4):2543-51. PubMed ID: 16888016
    [Abstract] [Full Text] [Related]

  • 18. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
    Clark NM, Berberov EM, Wang M, Moxley RA.
    Vet Immunol Immunopathol; 2006 Nov 15; 114(1-2):185-91. PubMed ID: 16919781
    [Abstract] [Full Text] [Related]

  • 19. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
    Miller TE, Phillips S, Simpson IJ.
    Clin Exp Immunol; 1978 Jul 15; 33(1):115-21. PubMed ID: 361314
    [Abstract] [Full Text] [Related]

  • 20. [A mechanism of human complement activation by immunostimulators from the bacterial cell wall].
    Kozlov LV, Zinchenko AA, Soliakov LS, Sizoĭ MN, Ishchenko AM.
    Bioorg Khim; 1983 Aug 15; 9(8):1047-55. PubMed ID: 6680304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.